Log in
Donate

Clinical Trial: ECOG-ACRIN EA4151

ECOG-ACRIN EA4151

Status: Closed

NCT#03267433

A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma in Minimal Residual Disease-Negative First Complete Remission

EA4151 is closed to accrual, effective October 3, 2024.

Tobacco Use Assessment Sub-Study (EAQ16T), Closed to Accrual, effective October 8, 2021.

View All Clinical Trials
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved